Clinical Trials Browser

Phase 1 × OTHER × Solid Tumor × Clear all

NCT06576037 2026-04-16

Phase Ib Study of CBP-1019 in Combination With FOLFOX +/- Bevacizumab, Pembrolizumab, or Enzalutamide for Metastatic TRPV6-overexpressing Solid Tumors of Epithelial Origin

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT05238792 2026-03-12

Multi Tumor-Associated Antigen-Specific T Lymphocytes to Treat Patients With High Risk Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT06563375 2026-03-12

Phase 1 Dose Escalation and Dose Expansion Trial of NP-101 in Patients With Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT05661201 2026-03-06

NEROFE and Doxorubicin in KRAS-mutated ST2-positive Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT05100251 2026-02-17

Clinical Trial of WBC100 on Advanced Solid Tumor

Phase 1 Terminated

Other solid neoplasm

Solid Tumor

NCT03875287 2026-01-12

Dose-Escalation Study of E7727, an Oral Cytidine Deaminase Inhibitor With Oral Decitabine in Subjects With Solid Tumors

Phase 1 Active not recruiting

Other solid neoplasm

Solid Tumor

NCT06349837 2025-12-17

Safety and Tolerability of LDRT Plus Concurrent Partial SBRT and Tislelizumab in Patients With Bulky Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT05322408 2025-11-05

HCW9218 in Select Advanced Solid Tumors

Phase 1 Completed

18 enrolled 17 charts

Other solid neoplasm

Solid Tumor

NCT04381806 2025-10-29

Phase I Study in Advanced Malignancies With 5-ALA

Phase 1 Suspended

Other solid neoplasm

Solid Tumor

NCT06894745 2025-07-22

PET [89Zr]DFO-starPEG in Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT06443710 2025-07-15

Technetium [99mTc]-H7ND in Patients With Gastrointestinal Malignancies and Healthy Volunteers

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT06883149 2025-06-10

PIN in Combination With Anti-PD1 in Previously Treated Solid Tumor

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT02608385 2025-06-08

Study of PD1 Blockade by Pembrolizumab With Stereotactic Body Radiotherapy in Advanced Solid Tumors

Phase 1 Active not recruiting

Other solid neoplasm

Solid Tumor

NCT06394622 2024-05-01

A Clinical Research About CD70-targeted CAR-NKT Cells Therapy Advanced Malignant Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT06101082 2024-03-06

A Clinical Study Evaluating the Safety and Efficacy of Anti-HER2-CAR-T Cells Injection in Patients With Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT05775666 2023-03-20

UCLM802 (Anti-Mesothelin CAR-T) Cell Injection in Patients With Mesothelin-positive Advanced Malignant Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Solid Tumor

NCT04316169 2022-12-23

Hydroxychloroquine, Abemaciclib and Endocrine Therapy in Hormone Receptor Positive (HR+)/Her 2 Negative Breast Cancer

Phase 1 Withdrawn

BreastOther solid neoplasm

Solid Tumor

NCT03051477 2022-12-08

Trial of Mistletoe Extract in Patients With Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT05246995 2022-02-18

A Phase I Study of IBI325 in Patients With Advanced Solid Tumor

Phase 1 Unknown

Other solid neoplasm

Solid Tumor

NCT05136937 2022-01-31

A Clinical Study of Intratumoral Administration of RT-01 in Patients With Advanced Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Solid Tumor

NCT03015324 2022-01-25

Biological Effects of Agent on PAR-4 Levels With Resected Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT03057145 2021-09-02

Combination Study of Prexasertib and Olaparib in Patients With Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT03471286 2021-08-26

A Window of Opportunity Study to Investigate Mechanisms of Actions of Novel Therapeutic Agents in Patients With Resectable Solid Tumor Malignancies

Phase 1 Terminated

Other solid neoplasm

Solid Tumor

NCT00786669 2021-02-10

VITAC

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT02987166 2020-12-16

UVA-AM-001

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT04360317 2020-04-24

Safety of the Combination of SH003 and Docetaxel in Patients With Solid Cancer

Phase 1 Unknown

Other solid neoplasm

Solid Tumor

NCT02466802 2020-02-20

Study of Regorafenib and Sildenafil for Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT03879057 2019-10-01

Trial of Surufatinib Combined With JS001 in the Treatment of Advanced Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Solid Tumor

NCT00215501 2018-11-02

Capecitabine or 5-Fluorouracil in Combination With Irinotecan and Cisplatin in Patients With Solid Tumor Malignancies

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT02648425 2018-10-25

Safety and Tolerability of ASLAN001 in Combination With Cisplatin and 5-FU or Cisplatin and Capecitabine

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT02593708 2017-11-17

Phase1 of Neratinib+Trastuzumab, Pertuzumab, Paclitaxel in Patients With Advanced Solid Tumors/HER2+

Phase 1 Terminated

Other solid neoplasm

Solid Tumor

NCT01929486 2016-02-17

Phase Ia/Ib Multicenter Trial of Mogamulizumab for Advanced or Recurrent Cancer.

Phase 1 Unknown

Other solid neoplasm

Solid Tumor

NCT00251407 2012-08-09

Taxotere, Cisplatin, and CPT-11 in Advanced Solid Tumor Malignancies

Phase 1 Completed

Other solid neoplasm

Solid Tumor